GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Current Deferred Taxes Liabilities

SkinBioTherapeutics (LSE:SBTX) Current Deferred Taxes Liabilities : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

SkinBioTherapeutics's current deferred tax liabilities for the quarter that ended in Dec. 2023 was £0.00 Mil.

SkinBioTherapeutics Current Deferred Taxes Liabilities Historical Data

The historical data trend for SkinBioTherapeutics's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Current Deferred Taxes Liabilities Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial - - - - -

SkinBioTherapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SkinBioTherapeutics Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


SkinBioTherapeutics (LSE:SBTX) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics (LSE:SBTX) Headlines

From GuruFocus

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

By Value_Insider Value_Insider 11-08-2022